Skip to content

Neuroendocrinology

ISSN 0028-3835

2 papers in the library · 11 citations · publishing 2008-2025

Papers

Progesterone Enhancement of Lysergic Acid Diethylamide and Levo-5-Hydroxytryptophan Stimulation of the Copulatory Response in the Female Rat

Neuroendocrinology March 26, 2008 Anni Sietnieks, Bengt J. Meyerson 11 citations

In female rats whose ovaries have been removed, sexual receptivity (the lordosis response) can be triggered by estrogen alone or estrogen plus progesterone. Large doses of LSD (≥50 μg/kg) or L-5-HTP (≥2.5 mg/kg) inhibit this behavior, with progesterone enhancing the inhibition. Conversely, small doses of LSD (5–30 μg/kg) increase lordosis when only estrogen is given. This study tested how different hormone treatments affect this stimulatory action. When lordosis was activated by estradiol benzoate alone, a 10 μg/kg dose of LSD increased the response within 10 minutes, but 1 μg/kg had no effect. However, when progesterone was also given, 1 μg/kg of LSD did increase lordosis. Similar results occurred with very small doses of L-5-HTP after certain pretreatments. Progesterone appears to influence serotonin-related mechanisms in this behavior.

A Systematic Review of the Effects of N-Methyl-D-Aspartate Receptor Antagonists on Pancreatic Islets

Neuroendocrinology October 30, 2025 Sabrina Wong, Gia Han Le, Jens Uhlig et al.

Blocking NMDA receptors improves the function and survival of pancreatic alpha and beta cells, which may help explain why certain NMDA antagonists like ketamine, esketamine, and dextromethorphan have antidepressant effects and could also address metabolic problems often seen in depression. The findings suggest a shared mechanism linking mood regulation and pancreatic hormone control. More research is needed on how low doses of these drugs affect pancreatic function and delta cells.